Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 2 Stomach Neoplasms 1 Psychological Well-Being 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Lung Neoplasms 1 Leiomyoma 1 Inflammation 1 Helicobacter Infections 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Anovulation 1

Interventions

Magnetic Resonance Spectroscopy 51 Specimen Handling 42 enzalutamide 36 Androgen Antagonists 35 Radiosurgery 33 Radiotherapy 31 darolutamide 26 Prednisone 26 Abiraterone Acetate 25 Leuprolide 22 Docetaxel 22 apalutamide 21 abiraterone 19 Pluvicto 19 Standard of Care 18 Triptorelin Pamoate 17 Radiation 17 Biopsy 16 relugolix 15 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 14 Blood Specimen Collection 13 gallium 68 PSMA-11 12 X-Rays 11 Surveys and Questionnaires 11 pembrolizumab 10 luprolide acetate gel depot 10 Carboplatin 10 Methods 9 Interviews as Topic 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostatic Neoplasms × Vitamin D × Clear all

NCT05838716 2026-01-15

ViPER

University of Rochester

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡